Inventiva S.A. IVA
$3.60
▲ +1.32% 24H
About
Inventiva S.A. is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies. With its research and development headquarters situated in France, the company dedicates its efforts to designing treatments for diseases with significant unmet medical needs, particularly in the fi…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryFrance
Employees114
TickerIVA
Statistics
Market Cap$696.4M
Revenue (TTM)$5.9M
Net Income—
Net Margin—
EPS—
P/E-2.03
P/S117.44
P/B-5.10
EV/EBITDA-6.92
ROE1241.6%
Dividend Yield—
Price$3.60
Data: Twelve Data · Revenue = mcap / P/S